Compartment syndrome, unspecified, subsequent encounter 1 T79.A0XD is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 2 The 2021 edition of ICD-10-CM T79.A0XD became effective on October 1, 2020. 3 This is the American ICD-10-CM version of T79.A0XD - other international versions of ICD-10 T79.A0XD may differ.
Use secondary code (s) from Chapter 20, External causes of morbidity, to indicate cause of injury. Codes within the T section that include the external cause do not require an additional external cause code. Type 1 Excludes.
Postoperative diagnosis: status post polytrauma left lower extremity status post motorcycle accident with elevated compartment pressure for the lateral as well as the medial compartments.
In this case, the fasciotomy meets the root operation definition of “Release;” freeing a body part from an abnormal physical constraint by cutting or by using force. The ICD-10-PCS code can be assigned multiple times for each compartment released (i.e., two compartment fasciotomy, four compartment fasciotomy, etc.).
Groups of organs or muscles are organized into areas called compartments. Strong webs of connective tissue called fascia form the walls of these compartments. Compartment syndrome occurs when excessive pressure builds up inside an enclosed muscle space in the body.
In PCS, fragmentation has the meaning of Breaking solid matter in a body part into pieces. Typically, we think of a Lithotripsy in the urinary tract, but now this fragmentation can be performed on clots and plaque as well. The ultrasonic Qualifier “0” would be selected for this device treatment. Look at the medical record documentation closely as it may mention “EkoSonic®”, which is the Endovascular System that provides the fragmentation technique. The EkoSonic catheter is comprised of two parts: The Infusion catheter and the ultrasonic core. The following is one Fragmentation table 02F showing the addition of the body part for Pulmonary Trunk, Artery and Vein:
These new PCS codes went into effect August 1 and enable CMS to conduct real-time surveillance and obtain real-world evidence in how these drugs are working and provide critical information on their effectiveness and how they can protect patients. These procedure codes are designated as non-O.R. procedures, there is no assigned MDC or MS-DRG.